← Insider buys

Column Group L P has bought stock on 39 days since Sep 2016

Director and 10% owner at Ngm Biopharmaceuticals Inc, and 2 other companies

SEC CIK 0001347769 · Filings on SEC.gov ↗

$90.6MBought
$370KSold
Feb 1Last buy

Column Group L P's record

3 months after each buy, from the first price a copier could get.

−25.9%Average
−28.4 ptsVs S&P 500
0 of 5Higher

5 buys since 2016 with 3 months of prices.

Companies

Every filing

41 filings since Sep 2016, newest first

NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$921K+1.0%Feb 1
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$49KJan 25
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$191KJan 23
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$27KJan 17
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.5M+1.0%Jan 12
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$684K+1.0%Nov 7
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$446KJun 6
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$2.1M+1.0%Jun 2
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$428K+1.0%May 17
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.9M+1.0%May 13
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.3M+1.0%May 11
CNSTSell

Constellation Pharmaceuticals Inc

10% owner

$370KFeb 19
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.1MSep 3
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.1MAug 31
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$331KAug 25
NGMBuy

Ngm Biopharmaceuticals Inc

Director and 10% owner

$1.1MAug 17
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$3.6M+2.0%Mar 25
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$3.4M+2.0%Mar 23
CNSTBuy

Constellation Pharmaceuticals Inc

10% owner

$937K+1.0%Mar 23
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$150KMar 6
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$1.1MMar 4
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$717KFeb 10
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$101KNov 6
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$52KOct 24
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$983K+1.0%Oct 21
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$1.1M+1.0%Oct 16
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$555KOct 11
CNSTBuy

Constellation Pharmaceuticals Inc

10% owner

$12.0M+30.0%Oct 7
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$3.1M+1.0%Aug 9
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$86KAug 7
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$61KAug 5
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$478KJun 21
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$418KJun 14
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$323KJun 11
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$338KJun 6
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$675KMay 22
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$248KMay 13
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$804KMay 9
NGMBuy

Ngm Biopharmaceuticals Inc

10% owner

$30.2M−101.0%Apr 10
IMDZBuy

Immune Design Corp.

10% owner

$11.0M+68.0%Oct 30
IMDZBuy

Immune Design Corp.

10% owner

$5.0M+25.0%Sep 22

Filings come from SEC EDGAR. Not investment advice.